When to Take Ginkgo Biloba: Optimal Timing

Short answer: timing is a second-order question here

If you are hunting for the hour of the day that makes ginkgo biloba work, you are starting from the wrong end. Ginkgo is not a stimulant and not a hormone, it has no sharp window of action, and a single capsule does nothing noticeable to your head. The two things that actually matter are whether the extract in your tub is standardised at all, and whether you take it consistently for weeks. The clock is the third variable and by far the smallest.

The point of this article is not to stretch those two sentences into five paragraphs. We will go through what is really inside a ginkgo extract, what the pharmacokinetics say about timing, what the large long-term trials found — because that part is uncomfortable and usually gets left out — who should not take it, and what the picture looks like on an Estonian shelf in terms of price and availability.

What is actually inside a ginkgo extract

Supplements made from ginkgo leaf are not comparable with one another. The extract used in the research is called EGb 761 and is standardised to contain 24% flavone glycosides and 6% terpene lactones (DeKosky et al., 2008). The terpene lactones include the ginkgolides and bilobalide, which occur in very small amounts in the plant itself; concentrating them is the entire point of the manufacturing process.

The number on the label therefore tells you far more than the brand does. If a tub says only "ginkgo biloba 500 mg", it is probably ground leaf powder rather than an extract, and those two are not the same product at different prices — they are different things. An extract carries two numbers on the label: the concentration ratio (typically 50:1) and the standardised content as a percentage. If those are missing, there is no reason to assume the contents match what was used in trials.

The same logic applies to form: capsule, tablet and liquid extract give different absorption profiles and different dosing precision. Form differences are a topic of their own, written up in the comparison of ginkgo biloba forms.

It is also worth understanding why the ginkgo mechanism story sounds so convincing. Ginkgolide B acts against platelet-activating factor, the flavone glycosides behave as antioxidants, and effects on the tone of small blood vessels have been described for the extract. Each of those makes a lovely sentence in a product description. The problem is that a mechanism shown in a test tube or an animal model is not the same thing as a measurable outcome in a human, and ginkgo is a textbook case of a strong mechanism story living alongside a weak clinical result. When marketing copy tells you more about mechanism than about outcome, it is usually because the outcome side is the weaker one.

In Estonia a food supplement must be notified to the Health Board before it is placed on the market. That is useful to know, but it is equally important to understand what the notification is not: it is not the efficacy assessment a medicine goes through, and it is not confirmation that the contents match the label. In the supplement world, reading the label stays the buyer's job, and nobody does that job for you.

Pharmacokinetics: what absorption says about timing

Ginkgo's active compounds absorb reasonably well and reach their plasma peak roughly one to three hours after ingestion. How long they persist differs, though: ginkgolide B stays around noticeably longer than bilobalide, which clears faster (Woelkart et al., 2010). That is the one place where timing has genuine pharmacological content.

The practical conclusion is simple. Because some compounds disappear within a few hours, splitting the daily amount in two keeps the level steadier than one large dose in the morning. That is exactly why the large clinical trials used twice-daily dosing rather than a single dose (DeKosky et al., 2008; Vellas et al., 2012).

The same pharmacokinetics also tell you what timing cannot do. It does not compensate for a weak extract, it does not compress the onset from weeks into days, and it does not make the effect bigger. Anyone hoping that shifting the clock from eight to ten produces a new result is looking for leverage where there is none.

With food or on an empty stomach

Ginkgo extract can be taken with or without food. Food pushes the peak slightly later, but that is not a reason to rearrange your day. The only argument that genuinely counts here is tolerability: a larger dose on an empty stomach causes mild nausea or stomach discomfort in some people, and a meal buffers that away.

From this comes the most sensible rule for a beginner: attach the dose to a meal you eat every day anyway. Not because food meaningfully improves absorption, but because breakfast is the only thing in your day that happens regularly enough to serve as a reminder. With ginkgo, a forgotten dose is a much bigger problem than a suboptimal one.

And if the dose is forgotten anyway, what then? Take it at the next meal if the day is still going, and skip it if evening has arrived. There is no point in doubling up the next day: ginkgo's effect builds over weeks and one missed capsule is not something that needs making up. That sounds like a trivial detail, but it is exactly where people make dosing mistakes — trying to compensate for something that does not need compensating.

Morning, evening and pre-workout: what holds up

A morning dose is a reasonable default simply because most study protocols started in the morning and because consistency is easier to maintain there. The second dose goes with lunch.

There are stories about vivid dreams and restless sleep with an evening dose. Strong evidence for that does not exist, and this is most likely a mix of expectation and isolated cases. The practical recommendation stays conservative anyway: if you take two doses a day, they fit into morning and lunch regardless, so a late dose is neither necessary nor particularly meaningful.

For a shift worker, "morning" simply means the start of their day, not eight o'clock. If your day begins at two in the afternoon, the first dose is at two and the second at six or seven. Following the clock rigidly gives no advantage here, because ginkgo's action is not tied to the circadian rhythm the way melatonin's is. The only thing that matters is that the two doses spread across your waking hours and that they land at a similar time each day.

Pre-workout use rests on the weakest ground of all. Ginkgo is sometimes marketed in the language of circulation and "pump", but that is not what serious trials have measured, and there is no evidence base for the effect people expect in a gym. If you are looking for pre-training support, the honest answer is that ginkgo is not the right tool. Timing questions with a similar but better-defined goal are covered in the L-theanine timing guide.

A practical schedule

An honest look at the evidence

Here comes the part most timing articles quietly skip. Ginkgo is one of the few plant supplements to have been put through genuinely large and long randomised trials, and the results were not good.

A six-week trial in healthy adults over 60 taking 40 mg of standardised extract three times a day found no measurable difference in memory, attention or other cognitive measures compared with placebo (Solomon et al., 2002). A large multi-year trial in which participants took 120 mg twice daily for a median of more than six years did not reduce the incidence of dementia relative to placebo (DeKosky et al., 2008). A five-year European trial at the same dose reached the same conclusion (Vellas et al., 2012). A Cochrane review summed the picture up by calling the evidence inconsistent and unreliable (Birks & Grimley Evans, 2009).

For the other commonly cited uses — tinnitus, circulation in the limbs, dizziness — the overall picture is similar: smaller and shorter studies have produced conflicting results, and large carefully conducted trials have not confirmed them. This is not unique to ginkgo; most plant extracts that have made it as far as genuinely large trials have travelled the same road from promising to modest.

What do you do with that? Two things. First: ginkgo is not something to expect disease prevention from, and no food supplement is. Second: a negative result at group level does not necessarily mean an individual notices nothing — it means the average benefit is so small that large trials could not detect it. If you buy ginkgo, buy it with a modest expectation and a fixed time limit, not as a long-term hope.

Who should skip ginkgo, and when it is genuinely risky

This is the most important section of the article and it should not be skimmed.

Ginkgo has been associated with bleeding events, particularly alongside other agents that affect clotting, and that risk has been reviewed separately in the literature (Bent et al., 2005). In practice this means the following. If you use warfarin, aspirin, clopidogrel or any other medication affecting coagulation, ginkgo is not a decision to make on your own — it is a decision to discuss with a doctor. The same applies if you have a clotting disorder.

Before planned surgery or a dental procedure where bleeding is expected, ginkgo should be stopped well in advance and the doctor should be told. Do not assume anyone will ask about supplements on their own; usually they do not.

The second and less well-known concern is not about clotting but about how the liver breaks down medicines. Plant extracts can influence the speed of drug metabolism and therefore the drug level in your blood — for some medicines that means a weaker effect, for others a stronger one. This type of effect has been described for ginkgo, and it is precisely why "but it is natural" is never a sufficient argument here. If your medication list contains anything whose dose has been carefully titrated, ask a pharmacist first.

Ginkgo is also unsuitable during pregnancy and breastfeeding, because safety data are lacking, and it is not for children. People with epilepsy and those on anticonvulsant medication also have reason to speak to a doctor first. And if you take several medicines at once, no table on the internet is sufficient — interactions are covered separately in the ginkgo interactions overview, but that does not replace a pharmacist's or doctor's assessment of your specific combination.

The question of long-term use is a topic in its own right, written up in the article on long-term ginkgo use.

What is actually on the Estonian shelf and what it costs

Ginkgo is a small category on the Estonian market. It is not vitamin D or magnesium, where every shop carries ten variants — the choice of standardised extract here is narrow, and that is useful to know before you start comparing brands. At the time of writing, the MaxFit ginkgo biloba range carries MST Ginkgo Biloba 60caps at 16.90 EUR. A pharmacy will usually stock some extract too, often at a higher price per capsule; when comparing, always compare the dose per capsule rather than the price of the tub, because the number of capsules in the tub hides the dose difference completely.

In the Estonian context there is also a clear seasonal pattern to ginkgo purchases. In November and December, when daylight is scarce and getting up in the morning is hard, people start looking for a tub that will clear their head. Ginkgo often ends up in that search simply because it has been on the market a long time and the name is familiar. But the fatigue of the dark season is not a problem caused by a lack of ginkgo, and it is not sensible to try to solve it with ginkgo.

And here comes the recommendation a supplement shop is not supposed to give, but which is honest. If your budget is limited and the goal is to feel sharper during the day, ginkgo is a poor first purchase. Sleep, iron status, vitamin D in winter and adequate protein do more for how you feel and how you concentrate than any plant extract. Protein is the easiest of those to sort out: at the time of writing BIOTECHUSA 100% Pure Whey 454g Õunakook costs 19.90 EUR and Optimum-nutrition Gold Standard 100% Whey 450g Vanillijäätis costs 24.90 EUR, roughly the same money as a tub of ginkgo but with a far more predictable effect. On the basics side, vitamin complexes and the protein range are a more sensible place to start.

An eight-week test, if you decide to try anyway

If you have read the above and still want to try, do it in a way that produces an answer.

First two weeks: one dose with breakfast, at the same time every day, and three specific things written down that you will track — afternoon concentration, word recall and light-headedness on standing, for example. A vague "do I feel better" is not a measure and always hands the win to placebo.

Weeks three to eight: two doses a day, morning and lunch, without changing any other supplement at the same time. If you start three new tubs at once, you will never know which one did anything.

At the end of week eight, make a decision. If the three things you wrote down have not moved, stop — this is not your supplement and the next tub will not change that. If something has moved, remember that placebo does exactly the same, and that a two-week break is the only way to tell the difference. Eight weeks is enough time to make sure a habit with no result does not turn into a fixed cost for years.

FAQ

How long does it take before ginkgo does anything?

If anything happens at all, it is on the scale of weeks rather than days; study protocols ran from months to years. A single dose before an exam or a meeting does nothing.

Can ginkgo be taken with coffee?

Yes, there is no direct problem and the combination is common. Just bear in mind that if you are evaluating results, the amount of coffee has to stay constant during the trial, otherwise you are measuring caffeine rather than ginkgo.

Are two doses a day better than one?

Pharmacokinetically yes, because some compounds clear quickly and a split dose keeps the level steadier (Woelkart et al., 2010). In practice, one dose you take every day beats two where the second one gets forgotten.

Is ginkgo compatible with blood-thinning medication?

That is not a decision to make without a doctor. Ginkgo has been associated with bleeding events, and combined with medication affecting coagulation this needs a medical assessment (Bent et al., 2005).

Does a more expensive tub mean a better extract?

It does not. Look at the standardisation and the dose per capsule on the label. Two similarly priced tubs can differ twofold in dose, and the capsule count tells you nothing about that.

Does ginkgo replace sleep?

No. No trial has shown that ginkgo compensates for sleep deprivation, and if your attention problem comes from six hours a night, it is not solvable from a tub.

References

Bent, S., Goldberg, H., Padula, A., & Avins, A. L. (2005). Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine, 20(7), 657-661. https://pubmed.ncbi.nlm.nih.gov/16050865/

Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, (1), CD003120.

DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., Kronmal, R. A., Ives, D. G., Saxton, J. A., et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253-2262. https://pubmed.ncbi.nlm.nih.gov/19017911/

Solomon, P. R., Adams, F., Silver, A., Zimmer, J., & DeVeaux, R. (2002). Ginkgo for memory enhancement: a randomized controlled trial. JAMA, 288(7), 835-840. https://pubmed.ncbi.nlm.nih.gov/12186600/

Vellas, B., Coley, N., Ousset, P. J., Berrut, G., Dartigues, J. F., Dubois, B., et al. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurology, 11(10), 851-859. https://pubmed.ncbi.nlm.nih.gov/22959217/

Woelkart, K., Feizlmayr, E., Dittrich, P., Beubler, E., Pinl, F., Suter, A., & Bauer, R. (2010). Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans. Phytotherapy Research, 24(3), 445-450. https://pubmed.ncbi.nlm.nih.gov/20041430/